Cecelia Boardman, MD
Gynecologic Oncology · Richmond, VANPI 1528158326
Payments from drug & device makers
Across 627 payments — averaging $1008.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$223K
- GSK$146K
- Tesaro, Inc.$57K
- Genentech, Inc.$55K
- Seagen Inc.$54K
- AbbVie$37K
- plus $60K from 29 others
What the payments were for
- Consulting fees$97,56717%
- Speaking & faculty fees$403,51370%
- Travel & lodging$59,78210%
- Food & beverage$15,5543%
- Education$3470%
- Gifts$2030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 189 | $223,393 |
| GSK | 115 | $145,996 |
| Tesaro, Inc. | 61 | $56,783 |
| Genentech, Inc. | 16 | $55,104 |
| Seagen Inc. | 33 | $54,084 |
| AbbVie | 37 | $36,931 |
| Merck | 55 | $23,527 |
| Genentech USA, Inc. | 20 | $15,985 |
| Immunogen, Inc. | 10 | $10,468 |
| Genmab U.S., Inc. | 3 | $5,616 |
| Pfizer | 9 | $1,193 |
| Eisai Inc. | 32 | $1,156 |
| Intuitive Surgical | 3 | $388 |
| Meditrina | 2 | $253 |
| Boston Scientific | 2 | $149 |
| Novartis | 4 | $114 |
| Myriad Genetic Laboratories, Inc. | 2 | $113 |
| Foundation Medicine, Inc. | 4 | $106 |
| Davol Inc. | 2 | $90 |
| Tempus AI, Inc | 3 | $86 |
| Clovis Oncology, Inc. | 6 | $80 |
| Momentis Surgical Inc. | 1 | $78 |
| Fennec Pharmaceuticals, Inc. | 3 | $56 |
| Caris MPI, Inc. | 2 | $54 |
| Cumberland Pharmaceuticals, Inc. | 2 | $34 |
| Johnson & Johnson(2 entities) | 2 | $33 |
| Verastem, Inc. | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Teleflex LLC | 1 | $25 |
| Astellas Pharma Global Development | 1 | $23 |
| Bayer | 1 | $21 |
| Array Biopharma Inc | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Baxter Healthcare | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$215,420
- ZEJULA$123,822
- JEMPERLI$72,342
- TIVDAK$57,993
- Elahere$46,496
- KEYTRUDA$22,794
- Avastin$15,666
- Da Vinci Surgical System$335
- LENVIMA$237
- GENERAL FEMALE SUI$121
How this compares
$632,069 in reported general payments places this provider in the 90th percentile of 47 gynecologic oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 22 | $935 |
| Dexamethasone | 33 | $859 |
| Letrozole | 45 | $842 |
| Pentoxifylline | 11 | $572 |
| Ondansetron OdtOndansetron | 21 | $496 |
| Fluconazole | 33 | $382 |
| Anastrozole | 11 | $288 |
| Prochlorperazine Maleate | 19 | $269 |
| Nystatin | 14 | $262 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $106 |
| Ciprofloxacin Hcl | 14 | $52 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Richmond
- Chelsea SalyerRichmond$393K
- Sarah TemkinRichmond$136K
- Richard BoothbyRichmond$41K
- Randal WestRichmond$8K
- Tyler FordRichmond$6K
- Johnny HydeRichmond$6K
- Paola GehrigRichmond$209
- John NashRichmond$125
- Charles JonesRichmond$15
- Linda DuskaCharlottesville$7.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.